logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Estrogen class drugs

    FiltersReset Filters
    19 results
    • balcoltra

      (levonorgestrel and ethinyl estradiol)
      Avion Pharmaceuticals
      Usage: Balcoltra is indicated for use in females of reproductive potential for the prevention of pregnancy.
    • bijuva

      (estradiol and progesterone)
      Mayne Pharma LLC
      Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
    • climara pro

      (Estradiol and Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.
    • delestrogen

      (estradiol valerate)
      ENDO USA, Inc.
      Usage: DELESTROGEN (estradiol valerate injection) is indicated for treating moderate to severe menopausal symptoms, vulvar and vaginal atrophy, hypoestrogenism from hypogonadism or ovarian failure, and for palliation of advanced androgen-dependent prostate cancer.
    • drospirenone and ethinyl estradiol

      (drospirenone and ethinyl estradiol)
      Mylan Pharmaceuticals Inc.
      Usage: Drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg) are indicated for female patients of reproductive potential as a contraceptive method to prevent pregnancy.
    • estrogel

      (estradiol)
      ASCEND Therapeutics US, LLC
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy associated with menopause. For vulvar and vaginal atrophy, topical vaginal products should be considered first if symptoms are the sole concern.
    • ethynodiol diacetate and ethinyl estradiol

      (ethynodiol diacetate and ethinyl estradiol)
      Mylan Pharmaceuticals Inc.
      Usage: Ethynodiol diacetate and ethinyl estradiol tablets are indicated for the prevention of pregnancy in women choosing oral contraceptives as their method of contraception. These tablets are effective in reducing unintended pregnancies when used correctly and consistently.
    • evamist

      (Estradiol)
      Padagis US LLC
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
    • imvexxy

      (estradiol)
      Mayne Pharma LLC
      Usage: This drug is indicated for the treatment of moderate to severe dyspareunia, which is a symptom of vulvar and vaginal atrophy resulting from menopause.
    • lo loestrin fe

      (norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate)
      Allergan, Inc.
      Usage: Lo Loestrin® Fe is indicated for the prevention of pregnancy in women. Its efficacy in women with a BMI greater than 35 kg/m² has not been evaluated.